168 related articles for article (PubMed ID: 16738854)
1. Spontaneous versus precipitated AUR: the same?
McNeil SA
World J Urol; 2006 Sep; 24(4):354-9. PubMed ID: 16738854
[TBL] [Abstract][Full Text] [Related]
2. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
Roehrborn CG; Bruskewitz R; Nickel GC; Glickman S; Cox C; Anderson R; Kandzari S; Herlihy R; Kornitzer G; Brown BT; Holtgrewe HL; Taylor A; Wang D; Waldstreicher J
Eur Urol; 2000 May; 37(5):528-36. PubMed ID: 10765090
[TBL] [Abstract][Full Text] [Related]
3. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
4. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
[TBL] [Abstract][Full Text] [Related]
5. Reporting of acute urinary retention in BPH treatment trials: importance of patient follow-up after discontinuation and case definitions.
Roehrborn CG
Urology; 2002 Jun; 59(6):811-5. PubMed ID: 12031358
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
Alan McNeill S
Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
8. The Reten-World survey of the management of acute urinary retention: preliminary results.
Emberton M; Fitzpatrick JM
BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
[TBL] [Abstract][Full Text] [Related]
10. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
McNeill SA; Hargreave TB; Roehrborn CG;
Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
[TBL] [Abstract][Full Text] [Related]
11. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
[TBL] [Abstract][Full Text] [Related]
12. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of medical treatment in benign prostatic hyperplasia.
Kim CI; Chang HS; Kim BK; Park CH
Urology; 2006 Nov; 68(5):1015-9. PubMed ID: 17095071
[TBL] [Abstract][Full Text] [Related]
14. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
[TBL] [Abstract][Full Text] [Related]
15. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.
Manikandan R; Srirangam SJ; O'Reilly PH; Collins GN
BJU Int; 2004 Jan; 93(1):84-8. PubMed ID: 14678374
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
Lee S; Yoo KH; Kim TS; Cho HJ; Kim W; Oh JK; Li S; Kim SY; Wei W; Huang J; van Uem S; Del Giudice F; Lindars DP; Sathe AR; Chung BI
Prostate; 2023 May; 83(7):722-728. PubMed ID: 36891865
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of intermittent catheterization for acute urinary retention: a prospective comparative randomized study].
Malkhasyan VA; Kotov SV; Mamaev IE; Belomytcev SV; Perov RA; Pulbere SA; Volnukhin AI; Pushkar DU
Urologiia; 2022 Dec; (6):9-15. PubMed ID: 36625607
[TBL] [Abstract][Full Text] [Related]
18. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
19. The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates to surgery.
Iscaife A; Dos Anjos G; Barbosa C; Nahas WC; Srougi M; Antunes AA
Int Braz J Urol; 2018; 44(4):765-770. PubMed ID: 29617085
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]